The most common chemicals that can be ingested and lead to greater than endogenous levels of gamma-hydroxybutyric acid (GHB) in decedents are salts of GHB, gamma-butyrolactone (GBL), and 1,4-butanediol (BD). Results for three deaths involving the ingestion of one or another of these three chemicals, which led to findings of GHB in the decedents, are presented. An extraction procedure that facilitates the quantitation of GHB was developed. If present in the same specimen, both GHB and GBL can be quantitated. To determine the GBL concentration, the specimen is first analyzed for existing GHB, the GBL is then converted to GHB, and the analysis is repeated. The difference between the results in molarity units can yield the GBL concentration. A separate procedure was utilized for estimating concentrations of BD. Specimens analyzed included urine, blood, ocular fluid, brain, and solutions consumed by the decedents prior to death. The procedures were found to be convenient in as much as they are relatively rapid, precise, and economical.
Introduction
The requests for analysis of gamma-hydroxybutyric acid (GHB) during death investigations in Hillsborough County, FL have increased with GHB's use as a substance of abuse. The same is true for gamma-butyrolactone (GBL) and 1,4-butanediol (BD). It has been found that BD and GBL are as toxic as GHB (1) (2) (3) . Accidental deaths with these substances probably result at least in part because safe doses are not known by the users and in part because other central nervous depressants including ethanol are simultaneously consumed. With the number of cases increasing, it has become necessary to develop quantitative procedures for GHB concentrations that are accurate, reproducible, and relatively simple. The analytical ene caps (VWR Scientific, Atlanta, GA). Heating for MSTFA derivatization was performed with a Pierce-Reacti-Therm III Heating/Stirring module and Reacti-Block T-1 for 16-ram diameter test tubes (Pierce Scientific, Rockford, IL). An Abbott Laboratories, model LN9527-01, microcentrifuge was used with 2-mL capable, polypropylene, ultramicrocentrifuge tubes from Rainin Instrument Co. (Woburn, MA). The pipettes were a Wheaton 100-1095 microliter calibra (Millville, NJ) and a Rainin Instrument M25 Microman. Supelco (Bellefonte, PA) 2-mL clear-glass crimp AutoSampler vials with step, 0.25-mL glass inserts, and snap caps were used for gas chromatography-mass spectrometery (GC-MS) analyses. All glass extraction tubes were silylized prior to use by the method of Fenimore et al. (18) .
Standard and control preparation
Aqueous GHB calibration solutions were prepared from GHB sodium salt and deionized water. The concentrations for GHB calibrators were 2000, 1000, 500, 250, 100, 50, 25, and 10 mg/L. A 100-mg/L GHB control solution was prepared from the Cerilliant standard solution. Both calibrators and controls were extracted and analyzed with each set of samples. For the conversion of GBL to GHB, a solution of 10mM sodium hydroxide in methanol was used. After preparation, the solutions were transferred to silylized 16 x 125-mm culture tubes and stored in the dark at room temperature.
Internal standards
Two internal standards were evaluated in this work. One internal standard was a methanolic solution of the sodium salt equivalent to a concentration of gamma-hydroxyvaleric acid, GVA, having a concentration of 25 lug per 1.25 mL. This was prepared by using GVL and a 10.0raM sodium hydroxide solution in methanol. If sodium hydroxide were present in the final internal standard solution, it would convert GBL in sample to GHB. Therefore, to ensure that no sodium hydroxide remained, 20% by weight in excess of GVL was used in the preparation, followed by extraction of the excess lactone by performing three successive extractions with octane. Specifically, in a capable culture tube, 12.0 luL of GVL and 10.0 mL of 10mM methanolic sodium hydroxide were pipetted, vortex mixed, and allowed to stand for four days. The solution was then evaporated under nitrogen for 15 min at 60~ The residue was then reconstituted in 10 mL of methanol. This solution was then extracted three times with 5-mL aliquots of octane to ensure removal of any remaining GVL. The methanolic phase was quantitatively transferred to a 500-mL volumetric flask and diluted to the fiducial mark with methanol. After mixing by inversion 50 times, this solution was transferred to silylized capable culture tubes and stored at room temperature in the dark. As an alternative, this solution could be prepared directly from the sodium salt of GVA, if available.
The second internal standard to be evaluated was GHB-d6. It was prepared as 4.0 lug per 0.100 mL of methalnol from dilution of the 1.0-mg/mL Cerilliant GHB-d 6 solution. The Cerilliant vial content, 1 mL, was diluted to 25 mL in a class A volumetric flask and the resulting solution was used in 0.100 mL aliquots during the extraction procedure when using GHBde as the internal standard.
Specimen collection procedure
All specimens were obtained from autopsies performed on the decedents. Whenever possible, urine, ocular fluid, brain tissue, and heart blood specimens were obtained for analyses. Stomach content, bile, and liver were also obtained but not analyzed for the cases presented here. The blood specimens were collected in Becton Dickinson Vacutainer | (Becton Dickinson Labware, Franklin Lakes, HJ) tubes having different colored stoppers. The color of each tube's stopper was indicative of the additives put in the tubes by the manufacturer. Lavender represents disodium EDTA; gray contains sodium fluoride and sodium oxalate; royal blue has disodium EDTA; and red contains no additives. Ocular fluid specimens were collected in redstoppered Vacutainer tubes. Urine was collected in Blue Max TM polypropylene conical tubes (Becton Dickinson). The brain tissue was collected in the same type of polypropylene tubes and digested prior to extraction (19) . All specimens were stored at 4~ prior to analyses and between analyses.
Extraction procedure for the analysis of GHB by GC-MS
Extractions were performed using urine, blood, ocular fluid, brain digest, and drinking solutions believed to contain GHB or GBL. UTAK blank serum and blank urine samples were used as negative controls. Initially, GHB-d~ was used as the internal standard. However, because it elutes only a few seconds before GHB, another internal standard was tested. GVA was chosen because it elutes almost 9 s after GHB and is easily distinguished from GHB. For all extractions, 25 luL of the test specimen were pipetted into a 2-mL ultramicrocentrifuge tube. To the 25 1JL of sample, 1.225 mL of the GVA methanolic solution was added. The tube was then capped and vortex mixed. The tube was placed into a microcentrifuge and centrifuged for 5 min at 12,000 rpm. Two-hundred microliters of the methanolic supernate were pipetted into a t6 x 125-mm silylized culture tube and evaporated under nitrogen for 20 rain at 40~ Derivatization was performed by adding 100 IJL of MSTFA and 100 luL of dry ethyl acetate and heating at 60~ for 30 rain in a Pierce Reacti-Therm III. The resulting solution was transferred to an autosample vial and tested via GC-MS. For the conversion of GBL to GHB, i mL of the 10mM NaOH in methanol solution was added to the 200 ~L of extracted sample and heated for 1 h at 60~ prior to evaporation.
Extraction procedure for analysis of BD via HPLC
Samples to be tested for BD were analyzed using high performance liquid chromatography. The specimens were extracted using acetonitrile (20) . The samples were derivatized using 3,5-dinitrobenzoyl chloride to form the di-ester derivative of 1,4-BD (21) . The di (dinitrobenzoyl) derivatives were used for detection and quantitation on HPLC with a photodiodearray detector (22) . The di (dinirobenzoyl) derivative had a retention time of 19.8 min.
For BD calibration, the solutions in the following concentrations were used: 10, 25, 50, 100, 250, and 500 mg/L. The limit of detection was 3 mg/L. The limit of quantitation was 10 mg/L. The upper limit of linearity was about 250 mg/L.
Samples were diluted as required to fall within the linear dynamic range.
Method of standard additions for the analysis of GHB
The method of standard additions (23) was used to analyze the ability to test GHB in different media. The standard calibrators were diluted to a concentration range of 10 mg/L to 500 mg/L by dilution ofa 1000-mg/L stock of aqueous GI-IB solution. The dilutions were made with blank urine and blank serum in volumetric glassware. The method was used on the urine and heart blood of case 1. The urine was first diluted by a factor of 25. From this solution, 200 IJL was dispensed into several silylized test tubes and 25 IJL of the appropriate media calibrators were added. After vortex mixing, 25-1JL aliquots of these solutions were than analyzed via the extraction procedure detailed previously and the GC-MS procedure described. The concentrations resulting from the GC-MS analysis were used to calculate the concentrations of the specimen aliquots. Specifically, a GC-MS concentration result was multiplied by 225 IJL, and then subtracted from this product was the known calibrator concentration multiplied by 25 IJL. This result was then divided by 200 IlL to give the concentration of the diluted urine specimen. This concentration was then multiplied by 25 to give the concentration of the original urine specimen. The same procedure was used for the heart blood, but without any initial dilution.
GC-MS analysis for GHB
The GC was a PerkinElmer AutoSystem model I with a split/splitless injector operated in the splitless mode. The MS was a PerkinElmer ion trap detector. The GC column used was a J&W Scientific (Folsom, CA) DB5-MS (30 m x 0.25 ram, 5-1~m column). In order to maintain sensitivity, prior to a series of about 80 injections, a new CapSaver insert (Alltech Associates, Inc., Deerfield, IL) and a Thermogreen septum (Supelco) were installed with concomitant removal of about 5 cm of column from the front of the column. The injector of the GC was at 275~ during use. The temperature program was 60~ (1 rain) to 85~ (1 rain) to 300~ (15 rain) at a rate of 30~
The split vent was opened at 0.5 min and closed at 24.5 rain. The helium head pressure was 15 psi. The linear velocity of helium was determined at 300~ to be 32.6 cm/s. The split flow was set to 10 mL/min. The GC-MS transfer line was set at 280~ Prior to all analyses, the MS was tuned with the automated TrapSet, the low mass axis was adjusted and the multiplier was set at the Quick Gain value plus 150 volts. The sensitivity was set to give an ion time of just less than 25,000 lJs. Injections were made using 1 lJL of fluid via the PerkinElmer AutoSys autosampler. The automatic gain control was set at a mass of 100. The MS was operated in the multiple ion detection mode (MID). The MID ranges were 115-120, 156-167, 200-206, and 230-249. A range of ions were used for quantitation rather than a single ion because of a observed slight increase in precision in linear calibration. Qualitative ions with percent relative abundance (in parentheses) were 117(67), 159(42), 204 (25) , 233(100), 234 (24) , and 235(12) for GHB-diTMS; 119(11), 165(80), 206 (16) , 239(100), 240 (28) , and 241(10) for GHB-d6-diTMS; and 117(53), 157(100), 158 (22),
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Journal of Analytical Toxicology, Vol. 25, October 2001 231(55), and 247(55) for GVA-diTMS. Quantitative ions for GHB-diTMS were 233, 234, and 235. For the internal standard GVA-diTMS, the quantitative ions were 230, 231, 232, and 233. When GHB-d6 was used as an internal standard, then the quantitative ions were 239, 240, and 241. Samples were diluted appropriately in order to fall within the linear dynamic range of the procedure.
Conversion of GBL to GHB
In order to test the conversion of GBL to GHB, solutions of GBL were prepared in pH 4 aqueous hydrochloric acid. This slightly acidic solution was chosen in order to ensure that the GVL had little tendency to hydrolyze to GHB (8) . The concentration of GBL was such that if converted completely to GHB, the solution would have a GHB concentration of 200 mg/L. Aliquots of this solution were processed by the GHB extraction procedure with GVA as the internal standard. The final methanolic extract solution was treated with NaOH as described in the extraction procedure detailed previously in order to convert GBL to GHB. The resultant solution was then quantitated for GHB via the GC-MS procedure.
Aliquots of the aqueous GBL solution were also extracted without treatment with NaOH. The resultant solutions were also analyzed via the GC-MS procedure.
Statistical analysis
Precision and accuracy of the reported values were calculated using different methods of statistical analysis. To determine the limit of detection, the limit of quantitation, and the upper limit of linearity, equations from Bonate (24) were employed. Comparative analysis between the use of different internal standards and the difference of concentrations reported for different methods were calculated using t-scores at p = 0.05. (25, 26) . For GHB, error as a function of concentration may be expressed as: gp = 0.00144 + 0.03856 c, where c represents concentration in milligrams per liter and op represents the population standard error of the mean (17) . The equation for gp was utilized in calculating t-scores. The gp was calculated from the results of duplicate controls (17) .
Results and Discussion
The cases discussed below were admitted to the Hillsborough County Medical Examiner's Department for autopsies. All toxicological analyses were conducted in the toxicology laboratory at the same location.
Case 1: a BD-related death
The decedent was a 21-year-old, 6 ft., 180 lb, white male who was employed as a computer technician and attended a local university, majoring in computer sciences. He and his friend, also a student at the local university as an engineering student, had entered a joint business venture where they had purchased BD from a chemical company via the Internet. They had diluted the 99.9% pure product by placing one capful of it into a 32-oz. bottle of water. They had intended to profit greatly from sales of the diluted solution. Soon, they received complaints from their customers that the diluted drug was not producing the desired euphoric effect.
The decedent spoke with his friend at approximately i a.m. the day of his death. The decedent had told his friend that he had consumed 6 to 7 capfuls of the diluted product and 1 capful of the undiluted chemical. The friend had noted that the decedent's speech was slurred. The time interval of consumption had been about I h.
At 3:45 a.m., the decedent's father found the decedent in the bathroom of the residence. The decedent was in a kneeling position in front of the toilet. His head and neck were pressed against the tile floor and bent posteriorly without obstruction to his nose or mouth, and the chest was not compressed. A portable telephone was next to him on the floor. Feces were present in the toilet and on the floor beneath his raised buttocks. Intense lividity was present caudally. Postmortem purge was on the floor around his head.
No liquid or drug paraphernalia were found about the body or in his bedroom. A computer in the bedroom was on-line to a drug information site. A police search of the decedent's vehicle located two 32-oz. bottles, one of which bore the label of BD. The other was unlabeled and was the suspected diluted product. Both bottles were brought to the medical examiner's department for testing.
The autopsy was performed within 7 h of death. Gross autopsy findings were significant for periorbital, conjuctival, and scleral petechiae. The cardiac chambers were dilated with liquid blood. The lungs were heavy and congested. The urinary bladder was dilated with clear pale urine.
Postmortem toxicology detected BD at a concentration of 70 mg/L in the peripheral blood and 78 mg/L in the heart blood, both sampled from red stopped tubes, and 870 mg/L in the urine, sampled from a polypropylene vial. The diluted solution had a determined level of 50,000 mg/L. The bottle labeled BD 99.9% was confirmed to be the alleged substance. The melting points for pure BD (Sigma Chemical Co., St. Louis, MO) and the undiluted chemical found at the scene were determined to be the same, 19.4-19.5~ In the decedent's heart blood, the weighted mean for the GHB concentration was 303 mg/L; in the urine, it was 1513 mg/L; and in the brain, it was 260 mg/kg.
The cause of death was intoxication by BD, and the manner of death was an accident. Although positional asphyxia may have been a component, the degree of which was uncertain given the previously described position. It appeared that he had become intoxicated by the drug prior to slipping off the toilet.
Case 2: a GBt-related death
The decedent was a 38-year-old white male with a past history of social illicit drug abuse. A security officer found him at 10:09 p.m. He was unresponsive, clothed, and sitting upright with his head tilted back and without airway or chest compression in the front passenger seat of his car in a local parking lot. On the driver's side floorboard was a 32-oz. bottle of Reviverant | with 15 mL of a clear yellow fluid remaining. According to the label, the ingredients were 2(3H) furanone dihydro, which is GBL; potassium citrate; potassium sorbate; riboflavin; and water. The dosage information indicated that one teaspoon should be mixed with citrus juice and that this could be repeated but that should not exceed a lethal dose of I oz. of the product. A multi-page manuscript was on the dashboard. The manuscript was an essay on beliefs pertaining to life, love, friendship, and relationships, but it did not mention suicide. It was not dated or signed. The legibility of the handwriting stayed constant throughout the manuscript. The bottle recovered from the floorboard was brought with the body to the medical examiner's department.
At autopsy, 10 h after the decedent was found, multiple linear horizontal old scars were identified on the volar aspect of the right antecubital fossa and forearm, suggestive of previous suicide attempt(s). The body was in full rigor mortis, and livor mortis was positional as stated. Other pertinent positive and negative gross findings were absence of intravenous or cutaneous injection sites, absence of petechiae, presence of blood tinged fluid within the tracheobronchial tree, and moderately heavy and congested lungs. The stomach contained 250 mL of fluid with a medicinal odor, which, when left standing, separated into two layers. The top layer was translucent orange with fatlike globules. The bottom layer was opaque grey. The bladder was distended with 400 mL of clear, lightamber urine.
Postmortem toxicology was positive for multiple drugs including GHB, GBL, methylenedioxymethamphetamine (MDMA), morphine, codeine, and 6-monoacetylmorphine (6-MAM). The concentrations of drugs detected in the urine were as follows: 320 mg/L, GHB; 66 mg/L, GBL; 1.12 mg/L, 6-MAM; 0.11 mg/L, codeine; and 3.10 mg/L, morphine. MDMA was detected in the urine but not quantitated. Only morphine was detected in the postmortem heart blood at a concentration of 0.07 mg/L. The contents of the bottle recovered from the decedent's vehicle had a determined concentration of 19,000 mg/L GBL. Further testing for GHB in the ocular fluid and brain detected levels of 37 mg/L and 44 mg/kg, respectively. Carboxyhemoglobin was also tested and determined to be 2%.
Death was attributed to chronic drug abuse from the combined effects of the drugs detected. The depressant action of GHB, GBL, and heroin may have caused him to become unconscious for a period of time prior to death allowing him to metabolize the majority of the drugs from the blood. The vast majority of the GHB detected was believed to have been produced from the ingested GBL. The manner of death was accidental, given no conclusive current suicidal tendencies.
Case 3: a GHB.related death
The decedent was a 20-year-old, 5 ft. 8 in., 143 lb, white male with a history of chronic illicit drug abuse and bipolar disorder. He had recently been admitted to a local hospital for drug intoxication where the toxicology screen had been positive for cocaine, benzodiazepines, and tricyclic antidepressants.
On the day of his death, he and his girlfriend had been out partying until 5:30 a.m. Upon returning home, they went to bed. The decedent's father knocking on the door awakened the girlfriend at approximately 6:30 p.m. She was unable to rouse the decedent, who was found on his side without airway obstruction. Rescue personnel were called, and they found the decedent without vital signs. He was transported to a local hospital, during which time full resuscitative efforts were employed, but unsuccessfully. He was pronounced dead at the hospital. Police interview of the father elicited information that the decedent may have ingested GHB prior to his death. Although he had a history of bipolar disorder, there were no suicidal tendencies. From the scene, a 16-oz. plastic Gatorade | bottle containing a blue solution in a was found. This plastic bottle was impounded and brought to the medical examiner's department for analysis.
The autopsy was performed 28 h after the decedent was last known to be alive. Gross findings were significant for the lungs being moderately heavy and congested. Petechiae were not present. The urinary bladder contained 5 mL of pale-yellow liquid. The patient had a urinary foley catheter in place, and the bag containing Color the withdrawn urine was not sent with the body. The stomach contained 150 mL of Lavender brown liquid, which had an aromatic odor. Microscopically, the pulmonary alveoli were filled with proteinaceous eosinophillic material with numerous hemosiderin-laden macrophages, rare neutrophils, and occaRed sional small collections of bacteria and food particles.
Royal blue Postmortem toxicology detected numerGrey ous drugs including GHB, methylenedioxyamphetamine, MDA, MDMA, morphine, and ethanol The concentrations of the drugs in the blood were 67 mg/L GHB, 0.43 mg/L MDA, 0.66 mg/L MDMA, 0.40 mg/L morphine, and 0.02 g/dL ethanol. The urine was negative for all drugs. This result may have been because the decedent had been catheterized and the previously formed urine was not available for analysis. GHB was detected in the ocular fluid at a concentration of 35 mg/L and in the brain 30 mg/kg. The GHB in the Gatorade bottle had a determined GHB concentration of 125,000 mg/L. Death was attributed to his chronic drug abuse from the combined effects of the drugs. The manner of death was accidental.
Numerical evaluation of the GHB procedures
The extraction methods using GVA or GHB-d6 as the internal standard were tested on many different samples, calibrators, controls, and blanks. Calibrators were used during each set of solutions that was subjected to GC-MS analysis. The calculated %CVs (23), within-run and between-run, for the heart blood and urine from case I are listed in Table I . They were calculated from results obtained using each internal standard.
Case 1 heart blood was sampled repeatedly from a lavendertop tube to determine the reproducibility of the procedure and the GHB concentration of the sample. The sample was analyzed using both internal standards and the standard addition technique. Using a t-test for comparison (Table II) , the concentrations quantitated from each analysis of the heart blood statistically show no difference. Results and compar- isons for blood from case 1 and other types of tubes are also given in Table II . The t-test was also used for the urine and again, no significant difference in concentration could be established (Table III) . The weighted means of all three cases used in this study are listed in Table IV . For case 1, the weighted means for the heart blood, urine, and ocular fluid were 303 rag/L, 1513 mg/L, and 165 rag/L, respectively. These concentrations were from analysis with both GVA and GHB-d6. GVA was the only internal standard used in the analyses of cases 2 and 3.
From the experiments performed for testing the conversion of GBL to GHB, the expected concentration was 200 mg/L and the determined concentration was 199 mg/L with a %CV of 0.5. This agreement demonstrates complete conversion of GBL to GHB within experimental error. For aliquots from the same initial GBL solution, extraction without the final NaOH treatment resulted in no detectable GHB. This result demonstrates that no conversion of GBL to GHB occurs without the NaOH treatment.
Linear regression analysis was used to generate calibration curves for the aqueous calibrators, 10-500 mg/L range, when using GVA or GliB-d6 as the internal standard. The GVA calibrators gave linear regression fits with R 2 > 0.99. The GHB-d6 also gave liner regression fits with R 2 > 0.99. The average recovery efficiency using either internal standard was between 87% and 92%. These recoveries were determined by comparing the results of extracted and unextracted standards from the GC-MS procedure. When using GVA as an internal standard, the limit of detection for GHB was 1.5 rag/L, the limit of quantitation was 4.9 mg/L, and the upper limit of linearity was 700 mg/L. When using GHB-d6 as an internal standard, the limit of detection for GHB was 2.0 rag/L, limit of quantitation was 6.5 rag/L, and the upper limit of linearity was 600 mg/L.
Conclusions
By comparing results in Table III for the method of standard addition in urine with those for linear calibration using aqueous calibrators, it may be seen that the results are indistinguishable. This observation demonstrates that it is valid to use aqueous calibrators with urine specimens with the presented extractions and linear calibrations. A similar conclusion may be reached for blood by comparing results within Table II . Such agreement might have been anticipated from the 50-fold sample dilution inherent in the extraction procedures. Furthermore, by comparing the results for different types of tubes within Table II , there appears to be no significant difference. The results for ocular fluid and brain in Table IV suggest that these specimens may be useful to indicate GHB ingestion; however, much more work needs to be done in order to determine postmortem endogenous concentrations.
It is apparent from the entries in Tables II and III that the procedures using GVA and GHB-d6 as internal standards yield indistinguishable results. However, the use of GVA might be preferred because of the different retention times for both the TMS derivatives of GVA and GHB, because of the relatively insignificant cost of GVA compared to GliB-d6 and because one less pipetting per sample was involved. The retention time difference allows for a more unique mass spectral identification (27) of the GHB-diTMS when GVA is used as opposed to GliBd6. Of course, GHB-d6 might be preferred when it is desired to quantitate exceedingly low concentrations of GHB. The use of GVA makes analysis of multiple samples cost and time efficient. It was determined that up to 60 samples can be extracted and derivatized within 4 h, depending on instrumentation available. In addition, the required sample amount is only 25 ]JL. This is ideal when specimens are available in small quantities.
The primary purpose in this work has been to present analytical procedures which the authors have found to be useful. The results for the three cases presented demonstrate some of the complexities involved in interpreting the impact of GHB in death investigations. There are many variables which need to be clarified by much future research before concentrations alone could be clearly related to death in a cause and effect sense. The phenomenon of postmortem production of GlIB further complicates interpretations (16, 28) .
